3-Spirocyclic Piperidine Derivatives for Gastrointestinal Motility
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for gastrointestinal dysmotility and related disorders, such as gastroparesis and functional dyspepsia, lack effective pharmacological options that target the ghrelin receptor to improve motility and associated symptoms.
Innovation Solution
Development of 3-spirocyclic piperidine derivatives that act as ghrelin receptor agonists, providing a novel class of compounds capable of enhancing gastrointestinal motility and addressing conditions characterized by reduced or restricted motility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for gastrointestinal dysmotility are used, then existing therapeutic options are maintained, but effective pharmacological options targeting the ghrelin receptor are lacking
Solution Approach 1:
The invention segments the broad field of gastrointestinal motility disorders into a specific targetable pathway by identifying ghrelin receptor agonism as a distinct mechanism of action, allowing for specialized drug development that addresses unmet medical needs in this therapeutic area
Solution Approach 2:
The invention changes the pharmacological parameter space by introducing compounds with specific molecular structures (3-spirocyclic piperidine derivatives) that exhibit ghrelin receptor agonist activity, thereby creating new therapeutic options with different mechanisms compared to existing treatments
2Adaptability or versatility
If novel ghrelin receptor agonists are developed, then treatment options for gastrointestinal dysmotility are enhanced, but the complexity of drug development increases
Solution Approach 1:
The invention applies local quality by introducing specific functional groups and structural features at particular positions within the piperidine core structure, optimizing the compounds for ghrelin receptor binding while maintaining manageable synthetic complexity
Solution Approach 2:
The invention uses composite molecular structures combining piperidine cores with various spirocyclic moieties and substituent groups, creating complex yet systematically designed molecules that target the ghrelin receptor with high specificity
Data Source
AI summary
The invention relates to derivatives of formula (I),wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of a disorder or a disease mediated by the ghrelin receptor.